Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SonoVue Sonoporation for Colorectal Cancer Liver Metastases
NCT03458975Phase 2Completed
- Sponsor
- University Hospital Tours
- Start
- Oct 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sulfur hexafluoride in Colorectal cancer with liver metastases (CRLM) (2 arms), sponsored by University Hospital Tours. Primary endpoint: Objective Response Rate at 2 months. Started Oct 2019; status: completed.
02
Drugs
sulfur hexafluoride
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03458975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03458975.